Scholars Central

Conference abstractPublished 2018

Clinical Oncology 2018: Development of PI3K inhibitor Copanlisib – New insights and outlook - Ningshu Liu - Bayer AG, Germany

Authors: Ningshu Liu

More from this journal

The newest in Research Journal of Oncology Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalResearch Journal of Oncology Open Access
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Ningshu Liu”